title: Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
authors.affiliation: Likoff Cardiovascular Institute, Department of Medicine, Hahnemann University, Philadelphia, Pennsylvania 19102-1192.
authors.forename: D G
authors.initials: DG
authors.lastname: Karalis
authors.forename: C
authors.initials: C
authors.lastname: Nydegger
authors.forename: R S
authors.initials: RS
authors.lastname: Porter
authors.forename: J
authors.initials: J
authors.lastname: Carver
authors.forename: I L
authors.initials: IL
authors.lastname: Pina
authors.forename: S P
authors.initials: SP
authors.lastname: Kutalek
authors.forename: E L
authors.initials: EL
authors.lastname: Michelson
mesh_terms: D000328:Adult; D000368:Aged; D000813:Anilides / Q000097:blood / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D015716:Electrocardiography, Ambulatory; D016700:Encainide; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D008297:Male; D008838:Microcomputers; D008875:Middle Aged; D010641:Phenotype; D005082:Physical Exertion
chemical_list: D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016700:Encainide